Clinical Trials Directory

Trials / Sponsors / Medinol Ltd.

Medinol Ltd.

Industry · 15 registered clinical trials — 1 currently recruiting.

StatusTrialPhaseStarted
SuspendedIonMAN II Trial- Early Feasibility Study of the IoNIR Ridaforolimus-Eluting Coronary Stent System
Coronary Stenosis, Coronary Artery Disease
N/A2025-08-07
RecruitingFirst In Human Study to Assess Safety and Efficacy of the ChampioNIR™ Drug Eluting Peripheral Stent in the Tre
Superficial Femoral Artery Stenosis, Popliteal Artery Stenosis
N/A2024-08-15
Active Not RecruitingIonMAN Trial- First in Human Study of the IoNIR Ridaforolimus-Eluting Coronary Stent System
Coronary Stenosis, Coronary Disease, Non-ST Elevated Myocardial Infarction
N/A2022-08-30
CompletedBIONICS Small Vessels Trial EluNIR Ridaforolimus Eluting Coronary Stent System (EluNIR) in Coronary Stenosis T
Coronary Stenosis, Coronary Disease, Myocardial Ischemia
—2020-12-31
TerminatedChampioNIR® SFA Stent EFS Study
Peripheral Arterial Disease
N/A2019-10-27
CompletedEluNIR Ridaforolimus Eluting Coronary Stent System in Patients at High Bleeding Risk (HBR)- EluNIR HBR Study
Coronary Stenosis
—2019-05-06
CompletedBIONICS 38 mm Trial EluNIR Ridaforolimus Eluting Coronary Stent System (EluNIR) In Coronary Stenosis Trial
Coronary Stenosis
N/A2018-11-14
CompletedMedJ-01 Ridaforolimus Eluting Coronary Stent System Trial (JNIR)
de Novo or Restenosis Lesions
N/A2017-01-16
CompletedBIONICS Israel Trial
Stenosis
N/A2016-09-01
CompletedBIONICS - Pharmacokinetics (PK) Trial
Heart Disease
—2016-04-01
CompletedNIRTRAKS Post-Market Study (NIRTRAKS)
de Novo Stenotic Lesions in Native Coronary Arteries
N/A2016-01-08
CompletedAngiography Study of BioNIR Drug Eluting Stent System (NIREUS)
Coronary Artery Stenosis
Phase 22014-03-19
CompletedStudy of BioNIR Drug Eluting Stent System in Coronary Stenosis
Coronary Artery Stenosis
N/A2014-01-01
CompletedX-MAS Biliary Study With Covered Biliary Stent
Biliary Tract Cancer
N/A2013-08-01
CompletedPIONIR Study (Presillion™ and Presillion™ Plus Stent Systems)
Ischemic Heart Disease
Phase 42009-04-01